China in talks with WHO over global use of Covid-19 vaccines

Published October 7, 2020
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus  vaccine, during a government-organised media tour in Beijing, China, September 24, 2020. — Reuters
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organised media tour in Beijing, China, September 24, 2020. — Reuters

SINGAPORE: China is in talks to have its locally-produced Covid-19 vaccines assessed by the World Health Organisation, as a step towards making them available for international use, a WHO official said on Tuesday.

Hundreds of thousands of essential workers and other groups considered at high risk in China have been given locally-developed vaccines even as clinical trials had not been fully completed, raising safety concerns among experts.

Socorro Escalate, WHO’s coordinator for essential medicines and health technologies in the Western Pacific region, told a news conference conducted online that China had held preliminary discussions with WHO to have its vaccines included in a list for emergency use.

The WHO’s emergency use listing procedure allows unlicensed vaccines and treatments to be assessed to expedite their availability in public health emergencies. This helps WHO member states and UN procurement agencies to determine the acceptability of the vaccines.

“Potentially through this emergency use listing the quality and safety of these vaccines and efficacy could be assessed... and then this could be made available for our licensees,” Escalante said.

China has at least four experimental vaccines in the final stage of clinical trials — two are developed by state-backed China National Biotec Group (CNBG), and the remaining two are from Sinovac Biotech and CanSino Biologics respectively. They are tested in such countries as Pakistan, Indonesia, Brazil, Russia and the United Arab Emirates.

Last month, the UAE authorised the emergency use of a CNBG vaccine, the first international emergency clearance for one of China’s vaccines, just six weeks after human trials began in the Gulf Arab state.

Published in Dawn, October 7th, 2020

Opinion

Editorial

Election time
Updated 27 Jan, 2023

Election time

There are concerns whether the ECP will be sufficiently able to protect the integrity of elections if they are held under partisan governments.
SCO invite
27 Jan, 2023

SCO invite

THOUGH India’s invitation to Pakistan to attend the Shanghai Cooperation Organisation events in Goa later this ...
Call to arms
27 Jan, 2023

Call to arms

ONE way the state abdicates responsibility in Pakistan is by farming out its functions to the private sector. In ...
Nuclear miscalculations
26 Jan, 2023

Nuclear miscalculations

IF the claim of former US secretary of state Mike Pompeo, that Pakistan and India came close to a nuclear exchange...
Exchange rate cap
26 Jan, 2023

Exchange rate cap

THE ‘management’ of the exchange rate by the State Bank, allegedly at the behest of the government, to ward off...
Fawad’s arrest
Updated 26 Jan, 2023

Fawad’s arrest

Does the state really need to fan public discontent in a period as fraught with uncertainty as this?